Skip to content
OpenCapital
Get started

Sabra Healthcare SBRA Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

American Healthcare REIT logo
American Healthcare REITAHR
$127.2M+635%
Welltower logo
WelltowerWELL
-$199.54M-115%
HCA Healthcare logo
HCA HealthcareHCA
-$830M+44.5%
AvalonBay Communities logo
AvalonBay CommunitiesAVB
-$431.94M-1,100%
VTR
VentasVTR
——
Encompass Health Corporation logo
Encompass Health CorporationEHC
——

Other financials

Income statement

See full
Revenue$221.8M+20.8%
Net income$40.9M+1.4%
EPS (diluted)$0.16-5.9%

Balance sheet

See full
Cash & equivalents$116.5M+414%
Total debt$7.3M-9.6%
Total equity$2.8B+3.1%
Total assets$5.6B+6.8%

Cash flow

See full
Operating cash flow$98.4M+22.5%

Valuation

See full
Market cap$4.57B+16.7%

Profitability

See full
Net margin19.2%-0.3pp

Returns & leverage

See full
Return on equity5.7%+0.5pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabra Healthcare's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sabra Healthcare's cash provided by (used in) financing activity, including discontinued operation?
Sabra Healthcare (SBRA) reported cash provided by (used in) financing activity, including discontinued operation of $52.1M in Q1 2026.
How has Sabra Healthcare's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Sabra Healthcare's cash provided by (used in) financing activity, including discontinued operation increased by 151.5% year-over-year, from -$101.24M to $52.1M.
What is the long-term trend for Sabra Healthcare's cash provided by (used in) financing activity, including discontinued operation?
Over 2 years (2022 to 2024), Sabra Healthcare's cash provided by (used in) financing activity, including discontinued operation has grown at a 6.0% compound annual growth rate (CAGR), from -$161.71M to -$181.56M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.